AR080891A1 - Proteina de fusion robo 1-fc y su utilizacion en el tratamiento de tumores - Google Patents
Proteina de fusion robo 1-fc y su utilizacion en el tratamiento de tumoresInfo
- Publication number
- AR080891A1 AR080891A1 ARP110101252A ARP110101252A AR080891A1 AR 080891 A1 AR080891 A1 AR 080891A1 AR P110101252 A ARP110101252 A AR P110101252A AR P110101252 A ARP110101252 A AR P110101252A AR 080891 A1 AR080891 A1 AR 080891A1
- Authority
- AR
- Argentina
- Prior art keywords
- robo
- fusion protein
- seq
- protein
- tumors treatment
- Prior art date
Links
- 206010028980 Neoplasm Diseases 0.000 title abstract 2
- 108020001507 fusion proteins Proteins 0.000 title 1
- 102000007056 Recombinant Fusion Proteins Human genes 0.000 abstract 2
- 108010008281 Recombinant Fusion Proteins Proteins 0.000 abstract 2
- 102000004169 proteins and genes Human genes 0.000 abstract 2
- 108090000623 proteins and genes Proteins 0.000 abstract 2
- 201000011510 cancer Diseases 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 230000002018 overexpression Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K19/00—Hybrid peptides, i.e. peptides covalently bound to nucleic acids, or non-covalently bound protein-protein complexes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/01—Hydrolysed proteins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Wood Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Pulmonology (AREA)
- Oncology (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Steroid Compounds (AREA)
Abstract
La presente solicitud se refiere a una proteína recombinante Robo 1-Fc y su utilizacion para tratar las enfermedades en las que se sobreexpresa una proteína Slit, en particular cáncer. Se refiere igualmente a una composicion que comprende tal proteína recombinante. Otro aspecto de la solicitud consiste en la utilizacion de una molécula Robo 1-Fc como herramienta de diagnostico para detectar la sobreexpresion de una molécula de la familia Slit en un paciente. Reivindicacion 8: Proteína segun una de las reivindicaciones 1 a 4 cuya secuencia presenta al menos 80% de identidad con la secuencia SEQ D Ns: 4, SEQ ID Ns:6 o SEQ ID Ns: 24.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR1052829A FR2958936A1 (fr) | 2010-04-14 | 2010-04-14 | Proteine de fusion robo1-fc et son utilisation dans le traitement des tumeurs |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR080891A1 true AR080891A1 (es) | 2012-05-16 |
Family
ID=42830780
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP110101252A AR080891A1 (es) | 2010-04-14 | 2011-04-13 | Proteina de fusion robo 1-fc y su utilizacion en el tratamiento de tumores |
Country Status (26)
| Country | Link |
|---|---|
| US (1) | US9493529B2 (es) |
| EP (1) | EP2558489A1 (es) |
| JP (1) | JP5858442B2 (es) |
| KR (1) | KR20130059329A (es) |
| CN (1) | CN102884076A (es) |
| AR (1) | AR080891A1 (es) |
| AU (1) | AU2011239839B2 (es) |
| BR (1) | BR112012026020A2 (es) |
| CA (1) | CA2796303A1 (es) |
| CL (1) | CL2012002879A1 (es) |
| CR (1) | CR20120508A (es) |
| DO (1) | DOP2012000265A (es) |
| EA (1) | EA201291044A1 (es) |
| EC (1) | ECSP12012230A (es) |
| FR (1) | FR2958936A1 (es) |
| GT (1) | GT201200275A (es) |
| IL (1) | IL222382A (es) |
| MA (1) | MA34221B1 (es) |
| MX (1) | MX338981B (es) |
| NI (1) | NI201200155A (es) |
| PE (1) | PE20130199A1 (es) |
| SG (1) | SG184529A1 (es) |
| TN (1) | TN2012000473A1 (es) |
| TW (1) | TW201142024A (es) |
| UY (1) | UY33334A (es) |
| WO (1) | WO2011128561A1 (es) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| UY33833A (es) * | 2010-12-23 | 2012-07-31 | Sanofi Sa | Proteína de fusión Robo1-Fc para su uso en el tratamiento del hepatocarcinoma |
| ES2714700T3 (es) | 2012-01-05 | 2019-05-29 | Boston Medical Ct Corp | Señalización de SLIT-ROBO para el diagnóstico y el tratamiento de una enfermedad de riñón |
| US11566082B2 (en) | 2014-11-17 | 2023-01-31 | Cytiva Bioprocess R&D Ab | Mutated immunoglobulin-binding polypeptides |
| CN107298715B (zh) * | 2016-04-15 | 2021-05-04 | 阿思科力(苏州)生物科技有限公司 | Slit2D2-嵌合抗原受体及其应用 |
| US10730908B2 (en) | 2016-05-11 | 2020-08-04 | Ge Healthcare Bioprocess R&D Ab | Separation method |
| CN109311949B (zh) | 2016-05-11 | 2022-09-16 | 思拓凡生物工艺研发有限公司 | 储存分离基质的方法 |
| WO2017194593A1 (en) | 2016-05-11 | 2017-11-16 | Ge Healthcare Bioprocess R&D Ab | Method of cleaning and/or sanitizing a separation matrix |
| US10889615B2 (en) | 2016-05-11 | 2021-01-12 | Cytiva Bioprocess R&D Ab | Mutated immunoglobulin-binding polypeptides |
| US10654887B2 (en) | 2016-05-11 | 2020-05-19 | Ge Healthcare Bio-Process R&D Ab | Separation matrix |
| CN109071613A (zh) | 2016-05-11 | 2018-12-21 | 通用电气医疗集团生物工艺研发股份公司 | 分离基质 |
| US10703774B2 (en) | 2016-09-30 | 2020-07-07 | Ge Healthcare Bioprocess R&D Ab | Separation method |
| JP7018458B2 (ja) * | 2017-06-02 | 2022-02-10 | ファイザー・インク | 組換えｒｏｂｏ２タンパク質、組成物、方法およびそれらの使用 |
| EP3672992A4 (en) | 2017-08-24 | 2021-05-19 | Bar-Ilan University | ROUNDABOUT FAMILY RECEPTOR INHIBITORS (ROBO) AND CORRESPONDING USES |
| US20220125879A1 (en) * | 2019-02-27 | 2022-04-28 | Daewoong Pharmaceutical Co., Ltd. | Albumin-bound composition including lrrd2 of slit3 protein for prevention or treatment of bone-related diseases |
| CA3136663A1 (en) * | 2019-04-23 | 2020-10-29 | The Regents Of The University Of California | Compositions and methods useful in promoting milk production |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6136310A (en) | 1991-07-25 | 2000-10-24 | Idec Pharmaceuticals Corporation | Recombinant anti-CD4 antibodies for human therapy |
| US20060122373A1 (en) | 1997-04-04 | 2006-06-08 | Millennium Pharmaceuticals, Inc. | Delta3, FTHMA-070, Tango85, Tango77, SPOIL,NEOKINE, Tango129 and integrin alpha subunit protein and nucleic acid molecules and uses thereof |
| JP2003517262A (ja) * | 1997-10-20 | 2003-05-27 | ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア | 神経誘導に含まれるポリペプチド及び核酸のファミリーであるｒｏｂｏ |
| JP2002510479A (ja) * | 1998-04-02 | 2002-04-09 | ライジェル・ファーマシューティカルズ・インコーポレイテッド | コンパクトな構造の形成を引き起こすペプチド |
| AU2001283062A1 (en) * | 2000-08-02 | 2002-02-13 | The Johns Hopkins University | Endothelial cell expression patterns |
| WO2003075860A2 (en) | 2002-03-08 | 2003-09-18 | Abgent, Inc. | Detection and modulation of slit and roundabount (robo) mediated angiogenesis and uses thereof |
| EP2311468B1 (en) * | 2003-08-08 | 2014-01-15 | Perseus Proteomics Inc. | Gene overexpressed in cancer |
| BRPI0507174A (pt) * | 2004-01-28 | 2008-04-01 | Syntonix Pharmaceuticals Inc | proteìnas de fusão hormÈnio-fc (fsh-fc) heterodiméricas estimuladoras de folìculo para o tratamento da infertilidade |
| RU2466740C2 (ru) * | 2006-04-05 | 2012-11-20 | Эбботт Байотекнолоджи Лтд. | Очистка антитела |
| CL2007003411A1 (es) | 2006-11-28 | 2008-07-04 | Centelion | Proteina fusion que consiste en una region fc de una inmunoglobulina con un fragmento o dominio soluble de un receptor para fgf; polinucleotido que la codifica y vector y celula que lo comprenden; composicion farmaceutica que comprende la proteina fu |
| EP2599791A1 (en) * | 2007-04-27 | 2013-06-05 | Genentech, Inc. | Potent, stable and non-immunosuppressive anti-CD4 antibodies |
| SG10201407388XA (en) | 2007-08-29 | 2015-01-29 | Sanofi Aventis | Humanized anti-cxcr5 antibodies, derivatives thereof and their uses |
| EP2050764A1 (en) | 2007-10-15 | 2009-04-22 | sanofi-aventis | Novel polyvalent bispecific antibody format and uses thereof |
-
2010
- 2010-04-14 FR FR1052829A patent/FR2958936A1/fr active Pending
-
2011
- 2011-04-08 MA MA35354A patent/MA34221B1/fr unknown
- 2011-04-08 CN CN2011800238283A patent/CN102884076A/zh active Pending
- 2011-04-08 PE PE2012002019A patent/PE20130199A1/es not_active Application Discontinuation
- 2011-04-08 CA CA2796303A patent/CA2796303A1/fr not_active Abandoned
- 2011-04-08 SG SG2012075107A patent/SG184529A1/en unknown
- 2011-04-08 MX MX2012011822A patent/MX338981B/es active IP Right Grant
- 2011-04-08 US US13/641,012 patent/US9493529B2/en active Active
- 2011-04-08 EP EP11719346A patent/EP2558489A1/fr not_active Withdrawn
- 2011-04-08 WO PCT/FR2011/050811 patent/WO2011128561A1/fr active Application Filing
- 2011-04-08 AU AU2011239839A patent/AU2011239839B2/en not_active Ceased
- 2011-04-08 JP JP2013504311A patent/JP5858442B2/ja not_active Expired - Fee Related
- 2011-04-08 EA EA201291044A patent/EA201291044A1/ru unknown
- 2011-04-08 KR KR1020127026724A patent/KR20130059329A/ko not_active Application Discontinuation
- 2011-04-08 BR BR112012026020A patent/BR112012026020A2/pt not_active IP Right Cessation
- 2011-04-13 AR ARP110101252A patent/AR080891A1/es unknown
- 2011-04-14 UY UY0001033334A patent/UY33334A/es not_active Application Discontinuation
- 2011-04-14 TW TW100113039A patent/TW201142024A/zh unknown
-
2012
- 2012-09-28 TN TNP2012000473A patent/TN2012000473A1/fr unknown
- 2012-10-05 DO DO2012000265A patent/DOP2012000265A/es unknown
- 2012-10-08 EC ECSP12012230 patent/ECSP12012230A/es unknown
- 2012-10-08 CR CR20120508A patent/CR20120508A/es unknown
- 2012-10-11 IL IL222382A patent/IL222382A/en not_active IP Right Cessation
- 2012-10-11 GT GT201200275A patent/GT201200275A/es unknown
- 2012-10-12 CL CL2012002879A patent/CL2012002879A1/es unknown
- 2012-10-12 NI NI201200155A patent/NI201200155A/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CL2012002879A1 (es) | 2013-03-22 |
| US9493529B2 (en) | 2016-11-15 |
| GT201200275A (es) | 2014-01-24 |
| BR112012026020A2 (pt) | 2016-06-28 |
| NI201200155A (es) | 2013-02-05 |
| IL222382A0 (en) | 2012-12-31 |
| WO2011128561A1 (fr) | 2011-10-20 |
| IL222382A (en) | 2016-06-30 |
| CN102884076A (zh) | 2013-01-16 |
| US20130039912A1 (en) | 2013-02-14 |
| FR2958936A1 (fr) | 2011-10-21 |
| PE20130199A1 (es) | 2013-03-09 |
| MX338981B (es) | 2016-05-06 |
| DOP2012000265A (es) | 2013-02-28 |
| KR20130059329A (ko) | 2013-06-05 |
| MX2012011822A (es) | 2012-11-12 |
| MA34221B1 (fr) | 2013-05-02 |
| ECSP12012230A (es) | 2012-11-30 |
| TW201142024A (en) | 2011-12-01 |
| CR20120508A (es) | 2012-11-01 |
| EA201291044A1 (ru) | 2013-04-30 |
| TN2012000473A1 (fr) | 2014-01-30 |
| JP2013523172A (ja) | 2013-06-17 |
| JP5858442B2 (ja) | 2016-02-10 |
| SG184529A1 (en) | 2012-11-29 |
| AU2011239839A1 (en) | 2012-11-08 |
| EP2558489A1 (fr) | 2013-02-20 |
| AU2011239839B2 (en) | 2015-08-20 |
| CA2796303A1 (fr) | 2011-10-20 |
| UY33334A (es) | 2011-12-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR080891A1 (es) | Proteina de fusion robo 1-fc y su utilizacion en el tratamiento de tumores | |
| BR112017007765A2 (pt) | composições de adenosina deaminase-2 (ada2), variantes do mesmo e métodos de usar o mesmo | |
| BR112016004095A2 (pt) | administração de enzimas de empobrecimento de quinurenina para a terapia contra tumores | |
| UY32882A (es) | (heteroarilmetil) tiohidantoínas sustituidas | |
| BR112012029975A2 (pt) | peptídeo como medicamento, em particular para o tratamento do câncer. | |
| BR112013026032A2 (pt) | composições nutricionais incluindo ácidos graxos de cadeia ramificada para cicatrização de ferida | |
| UY32302A (es) | Carboxamidas heterobicíclicas como inhibidoras de cinasas | |
| BR112015029386A2 (pt) | uso de eribulina e lenvatinibe como terapia de combinação para tratamento de câncer | |
| CL2012001405A1 (es) | Compuestos derivados de espiroindolinona-pirrolidinas; proceso de obtención; composicion farmaceutica; y uso en el tratamiento o profilaxis del cancer. | |
| EP3722810A3 (en) | Molecular profiling of tumors | |
| ECSP10010697A (es) | Inhibidores de dpp-iv para uso en el tratamiento de nafld | |
| BR112012012918A8 (pt) | Agente indutor de apoptose para o tratamento de câncer e de doenças imunes e autoimunes | |
| EP2285989A4 (en) | NEW TARGETS TO REGULATE ANGIOGENESIS | |
| BRPI0816784A8 (pt) | Fatores neuro-endócrinos para o tratamento de doenças degenerativas | |
| AR069393A1 (es) | Inhibicion del receptor para la proteina estimulante del macrofago (ron) y metodos para el tratamiento del mismo | |
| BRPI0923300A2 (pt) | "derivados de nitrato de cilostazol para o tratamento de doenças vasculares e metabólicas" | |
| CL2007000161A1 (es) | Compuestos derivados de 2,4-dioxoimidazolidina sustituida, inhibidores de proteinas cinasas; composicion farmaceutica; y uso en el tratamiento de enfermedades tales como cancer. | |
| EP3747457A3 (en) | Factor 1 protein, factor 2 protein and inhibitors thereof for use in treating or preventing diseases | |
| BR112013026976A2 (pt) | alfa glucosidade ácida modificada com processamento acelerado | |
| UY30158A1 (es) | Uso de derivados de benzo-heteroaril sulfamida para el tratamiento del dolor | |
| WO2017151860A8 (en) | Human kynureninase enzyme variants having improved pharmacological properties | |
| WO2008060945A3 (en) | Diagnosis and treatment of breast cancer | |
| BR112015006363A2 (pt) | combinações farmacêuticas compreendendo ligantes angiopoietina-2/dll4 duplos e agentes anti-vegf-r | |
| GT201300125A (es) | 1h-pirazol-5-olato sódico sustituido | |
| CO6741197A2 (es) | Proteína de fusión robo1-fc para uso en el tratamiento del hepatocarcinoma |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |